scispace - formally typeset
S

Samuel S. Engel

Researcher at Merck & Co.

Publications -  137
Citations -  8441

Samuel S. Engel is an academic researcher from Merck & Co.. The author has contributed to research in topics: Sitagliptin & Type 2 diabetes. The author has an hindex of 38, co-authored 134 publications receiving 7501 citations. Previous affiliations of Samuel S. Engel include Yeshiva University & Albert Einstein College of Medicine.

Papers
More filters
Journal ArticleDOI

Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.

TL;DR: Traditional and emerging cardiac risk factors and inflammatory and prothrombotic markers were not associated with abnormal stress tests, although cardiac autonomic dysfunction was a strong predictor of ischemia.
Journal ArticleDOI

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and complications trial

Neil H. White, +324 more
TL;DR: The persistent difference in diabetic retinopathy between former intensive and conventional therapy ("metabolic memory") continues for at least 10 years but may be waning.
Journal ArticleDOI

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

TL;DR: The vast majority of patients with T2DM have multiple comorbidities, and the presence of multimorbidity should be considered in the context of clinical decision making.